PortfoliosLab logoPortfoliosLab logo
TSEM vs. TEVA
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

TSEM vs. TEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tower Semiconductor Ltd (TSEM) and Teva Pharmaceutical Industries Limited (TEVA). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

TSEM vs. TEVA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TSEM
Tower Semiconductor Ltd
59.32%127.96%68.77%-29.35%8.87%53.68%7.32%63.23%-56.75%79.09%
TEVA
Teva Pharmaceutical Industries Limited
-3.08%41.61%111.11%14.47%13.86%-16.99%-1.53%-36.45%-18.63%-46.18%

Fundamentals

Market Cap

TSEM:

$21.36B

TEVA:

$35.48B

EPS

TSEM:

$1.94

TEVA:

$1.21

PE Ratio

TSEM:

96.51

TEVA:

25.03

PEG Ratio

TSEM:

3.40

TEVA:

0.19

PS Ratio

TSEM:

13.59

TEVA:

2.04

PB Ratio

TSEM:

7.35

TEVA:

4.48

Total Revenue (TTM)

TSEM:

$1.57B

TEVA:

$17.26B

Gross Profit (TTM)

TSEM:

$363.85M

TEVA:

$8.94B

EBITDA (TTM)

TSEM:

$520.83M

TEVA:

$3.80B

Returns By Period

In the year-to-date period, TSEM achieves a 59.32% return, which is significantly higher than TEVA's -3.08% return. Over the past 10 years, TSEM has outperformed TEVA with an annualized return of 31.54%, while TEVA has yielded a comparatively lower -5.21% annualized return.


TSEM

1D
6.60%
1M
34.98%
YTD
59.32%
6M
150.13%
1Y
412.94%
3Y*
63.92%
5Y*
45.27%
10Y*
31.54%

TEVA

1D
0.43%
1M
-10.42%
YTD
-3.08%
6M
50.80%
1Y
97.84%
3Y*
50.64%
5Y*
21.38%
10Y*
-5.21%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TSEM vs. TEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TSEM
TSEM Risk / Return Rank: 9999
Overall Rank
TSEM Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
TSEM Sortino Ratio Rank: 9999
Sortino Ratio Rank
TSEM Omega Ratio Rank: 9898
Omega Ratio Rank
TSEM Calmar Ratio Rank: 9999
Calmar Ratio Rank
TSEM Martin Ratio Rank: 100100
Martin Ratio Rank

TEVA
TEVA Risk / Return Rank: 9292
Overall Rank
TEVA Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
TEVA Sortino Ratio Rank: 9292
Sortino Ratio Rank
TEVA Omega Ratio Rank: 9191
Omega Ratio Rank
TEVA Calmar Ratio Rank: 9292
Calmar Ratio Rank
TEVA Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TSEM vs. TEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tower Semiconductor Ltd (TSEM) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TSEMTEVADifference

Sharpe ratio

Return per unit of total volatility

6.60

2.33

+4.27

Sortino ratio

Return per unit of downside risk

5.10

3.11

+1.99

Omega ratio

Gain probability vs. loss probability

1.70

1.42

+0.27

Calmar ratio

Return relative to maximum drawdown

16.96

4.44

+12.52

Martin ratio

Return relative to average drawdown

61.93

12.93

+49.00

TSEM vs. TEVA - Sharpe Ratio Comparison

The current TSEM Sharpe Ratio is 6.60, which is higher than the TEVA Sharpe Ratio of 2.33. The chart below compares the historical Sharpe Ratios of TSEM and TEVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


TSEMTEVADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

6.60

2.33

+4.27

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.03

0.50

+0.52

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.75

-0.11

+0.86

Sharpe Ratio (All Time)

Calculated using the full available price history

0.01

0.31

-0.30

Correlation

The correlation between TSEM and TEVA is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

TSEM vs. TEVA - Dividend Comparison

Neither TSEM nor TEVA has paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
TSEM
Tower Semiconductor Ltd
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.88%3.19%1.77%

Drawdowns

TSEM vs. TEVA - Drawdown Comparison

The maximum TSEM drawdown since its inception was -99.75%, which is greater than TEVA's maximum drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for TSEM and TEVA.


Loading graphics...

Drawdown Indicators


TSEMTEVADifference

Max Drawdown

Largest peak-to-trough decline

-99.75%

-90.89%

-8.86%

Max Drawdown (1Y)

Largest decline over 1 year

-25.04%

-21.79%

-3.25%

Max Drawdown (5Y)

Largest decline over 5 years

-55.39%

-43.70%

-11.69%

Max Drawdown (10Y)

Largest decline over 10 years

-62.28%

-88.71%

+26.43%

Current Drawdown

Current decline from peak

-68.73%

-55.29%

-13.44%

Average Drawdown

Average peak-to-trough decline

-85.55%

-31.90%

-53.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.86%

7.49%

-0.63%

Volatility

TSEM vs. TEVA - Volatility Comparison

Tower Semiconductor Ltd (TSEM) has a higher volatility of 28.33% compared to Teva Pharmaceutical Industries Limited (TEVA) at 11.82%. This indicates that TSEM's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


TSEMTEVADifference

Volatility (1M)

Calculated over the trailing 1-month period

28.33%

11.82%

+16.51%

Volatility (6M)

Calculated over the trailing 6-month period

48.45%

27.30%

+21.15%

Volatility (1Y)

Calculated over the trailing 1-year period

63.10%

42.20%

+20.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.37%

42.76%

+1.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.13%

47.20%

-5.07%

Financials

TSEM vs. TEVA - Financials Comparison

This section allows you to compare key financial metrics between Tower Semiconductor Ltd and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
440.21M
4.71B
(TSEM) Total Revenue
(TEVA) Total Revenue
Values in USD except per share items

TSEM vs. TEVA - Profitability Comparison

The chart below illustrates the profitability comparison between Tower Semiconductor Ltd and Teva Pharmaceutical Industries Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
26.7%
56.4%
Portfolio components
TSEM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Tower Semiconductor Ltd reported a gross profit of 117.61M and revenue of 440.21M. Therefore, the gross margin over that period was 26.7%.

TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported a gross profit of 2.66B and revenue of 4.71B. Therefore, the gross margin over that period was 56.4%.

TSEM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Tower Semiconductor Ltd reported an operating income of 70.83M and revenue of 440.21M, resulting in an operating margin of 16.1%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported an operating income of 1.27B and revenue of 4.71B, resulting in an operating margin of 26.9%.

TSEM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Tower Semiconductor Ltd reported a net income of 80.13M and revenue of 440.21M, resulting in a net margin of 18.2%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Teva Pharmaceutical Industries Limited reported a net income of 480.00M and revenue of 4.71B, resulting in a net margin of 10.2%.